ÂÜÀòÂÒÂ×

Connor received his Ph.D. in Biomedical Engineering at Oregon Health & Science University in 2018, where he worked on the development of novel targeted fluorescent contrast agents for tumor margin detection and nerve detection during fluorescence guided surgery. During his graduate work, he received the Charles Patrick Memorial Fellowship and authored five first-author publications. Since graduating, he has devoted himself to the commercialization and clinical translation of the promising structure-inherent targeting nerve-specific fluorophores. With over 5 years of experience developing FGS technologies, Connor is budding entrepreneur who is highly coachable and quickly becoming an effective leader of Inherent Targeting.